HRT Financial’s Lexaria Bioscience Warrant LEXXW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-105,491
Closed 4312
2025
Q4
$0 Buy
105,491
+94,177
+832% +$3.32K ﹤0.01% 3633
2025
Q3
$0 Buy
+11,314
New +$1.33K ﹤0.01% 3305

HRT Financial's LEXXW Position: Q1 2026 in Review

HRT Financial sold out of Lexaria Bioscience Warrant (LEXXW) in Q1 2026, closing a stake of 105,491 shares.

HRT Financial first reported a position in LEXXW in Q3 2025 and held it in 2 quarters. The position peaked at $0 in Q4 2025. 0 funds tracked by Wall St. Rank hold LEXXW as of Q1 2026.

  • HRT Financial reported no remaining Lexaria Bioscience Warrant position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 105,491 Lexaria Bioscience Warrant shares in Q1 2026.
  • HRT Financial first reported a position in Lexaria Bioscience Warrant in Q3 2025 and held it in 2 quarters.
  • HRT Financial's Lexaria Bioscience Warrant position peaked at $0 in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Lexaria Bioscience Warrant as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.